McConway J, O'Brien S, Doran E, Archbold P, Beverland D
Outcomes Unit Musgrave Park Hospital, Stockman's Lane, Belfast, Northern Ireland BT9 7JB.
J Bone Joint Surg Br. 2007 Dec;89(12):1581-5. doi: 10.1302/0301-620X.89B12.19195.
Between April 1992 and July 2005, 310 posterior lip augmentation devices were used for the treatment of recurrent dislocation of the hip in 307 patients who had received primary total hip replacements (THRs) using Charnley/Charnley Elite components with a cemented acetabulum. The mean number of dislocations before stabilisation with the device was five (1 to 16) with a mean time to this intervention from the first dislocation of 3.8 years (0 days to 22.5 years). The mean age of the patients at this reconstruction was 75.4 years (39 to 96). A retrospective clinical and radiological review was carried out at a mean follow-up of six years and nine months (4.4 months to 13 years and 7 months). Of the 307 patients, 53 had died at the time of the latest review, with a functioning THR and with the posterior lip augmentation device in situ. There were four revisions (1.3%), one for pain, two for deep infection and one for loosening of the acetabular component. Radiolucent lines around the acetabular component increased in only six cases after insertion of the device which was successful in eliminating instability in 302 patients, with only five further dislocations (1.6%) occurring after its insertion.
1992年4月至2005年7月期间,310个后唇增强装置被用于治疗307例接受初次全髋关节置换术(THR)的复发性髋关节脱位患者,这些患者使用的是带有骨水泥髋臼的Charnley/Charnley Elite组件。在使用该装置稳定脱位之前,脱位的平均次数为5次(1至16次),从首次脱位到此次干预的平均时间为3.8年(0天至22.5年)。此次重建时患者的平均年龄为75.4岁(39至96岁)。在平均随访6年9个月(4.4个月至13年7个月)时进行了回顾性临床和放射学评估。在307例患者中,53例在最近一次评估时已死亡,其全髋关节置换功能正常且后唇增强装置仍在位。有4例翻修(1.3%),1例因疼痛,2例因深部感染,1例因髋臼组件松动。在植入该装置后,髋臼组件周围的透光线仅在6例中增加,该装置成功消除了302例患者的不稳定,植入后仅发生了5次进一步脱位(1.6%)。